Portage Biotech
PRTG
#10231
Rank
S$20.02 M
Marketcap
Country
S$8.79
Share price
-2.16%
Change (1 day)
71.80%
Change (1 year)

Portage Biotech (PRTG) - Cash on Hand

Cash on Hand as of March 2025 : S$2.15 Million

According to Portage Biotech's latest financial reports the company has S$2.15 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Portage Biotech - Cash on Hand chart (from 2000 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2025-03-31S$2.24 M-66.9%
2024-03-31S$6.77 M-51.68%
2023-03-31S$14.02 M-55.66%
2022-03-31S$31.62 M748.84%
2021-03-31S$3.72 M-18.61%
2020-03-31S$4.57 M-46.08%
2019-03-31S$8.48 M-14.49%
2018-03-31S$9.92 M-87.96%
2017-03-31S$82.49 M1204.93%
2016-03-31S$6.32 M167.92%
2015-03-31S$2.35 M-7.72%
2014-03-31S$2.55 M-37.91%
2013-03-31S$4.11 M1043.46%
2012-03-31S$0.36 M-87.65%
2011-03-31S$2.91 M-43.52%
2010-03-31S$5.16 M197.1%
2009-03-31S$1.73 M-73.49%
2008-03-31S$6.55 M-21.25%
2007-03-31S$8.32 M18.32%
2006-03-31S$7.03 M447.95%
2005-03-31S$1.28 M101.35%
2004-03-31S$0.63 M2570.81%
2003-03-31S$0.02 M-56.76%
2002-03-31S$0.05 M-39.16%
2001-03-31S$0.09 M-93.17%
2000-03-31S$1.32 M797.98%
1999-03-31S$0.14 M2180.86%
1998-03-31S$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NRC Health
NRC
S$2.86 M 32.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
S$0.17 M-92.10% Bahamas